Abstract
Budipine is a new antiparkinsonian drug which has been shown to ameliorate the major parkinsonian symptoms such as tremor, akinesia, and rigidity. It may have some influence on dopamine release and uptake and may also possess anticholinergic properties and exert definite stimulatory effects on the serotonergic receptors (Menge and Brand 1982).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fahn S, Calne DB (1978) Consideration in the management of parkinsonism. Neurology (Minneap) 28: 5–8
Menge HG, Brand U (1982) Pharmacological summary of Budipine, a new 4,4-diphenylpiperidine derivative used in treating Parkinson’s disease. Arzneimittelforsch 32: 85–98
Luo Y et al. (1982) The drug therapy of primary Parkinson’s disease in the elderly. Clin J Geriatr 1: 129
Wang X (1982) The clinical observation of the therapeutic effect of Lisuride in treatment of Parkinson’s disease. Clin J Nerv Ment Dis 8: 209
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Xinde, W. (1985). Observations on the Therapeutic Effect of Budipine on Parkinson’s Disease. In: Gerstenbrand, F., Poewe, W., Stern, G. (eds) Clinical Experiences with Budipine in Parkinson Therapy. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-95455-9_22
Download citation
DOI: https://doi.org/10.1007/978-3-642-95455-9_22
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-13764-1
Online ISBN: 978-3-642-95455-9
eBook Packages: Springer Book Archive